Your browser doesn't support javascript.
Now is the Time to Improve Cognitive Screening and Assessment for Clinical and Research Advancement.
Ashford, J Wesson; Schmitt, Frederick A; Bergeron, Michael F; Bayley, Peter J; Clifford, James O; Xu, Qun; Liu, Xiaolei; Zhou, Xianbo; Kumar, Vinod; Buschke, Herman; Dean, Margaret; Finkel, Sanford I; Hyer, Lee; Perry, George.
  • Ashford JW; War Related Illness and Injury Study Center, VA Palo Alto HCS, Palo Alto, CA, USA.
  • Schmitt FA; Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA.
  • Bergeron MF; Medical, Scientific, Memory Screening Advisory Board, Alzheimer's Foundation of American (AFA), New York, USA.
  • Bayley PJ; Medical, Scientific, Memory Screening Advisory Board, Alzheimer's Foundation of American (AFA), New York, USA.
  • Clifford JO; Departments of Neurology, Psychiatry, Neurosurgery, Psychology, Behavioral Science; Sanders-Brown Center on Aging, Spinal Cord & Brain Injury Research Center, University of Kentucky, Sanders-Brown Center on Aging, Lexington, KY, USA.
  • Xu Q; SIVOTEC Analytics, Boca Raton, FL, USA.
  • Liu X; War Related Illness and Injury Study Center, VA Palo Alto HCS, Palo Alto, CA, USA.
  • Zhou X; Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, USA.
  • Kumar V; Medical, Scientific, Memory Screening Advisory Board, Alzheimer's Foundation of American (AFA), New York, USA.
  • Buschke H; College of San Mateo, San Mateo, CA, USA.
  • Dean M; Health Management Center, Department of Neurology, Renji Hospital of Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Finkel SI; Department of Neurology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
  • Hyer L; Yunnan Provincial Clinical Research Center for Neurological Diseases, Yunnan, China.
  • Perry G; Center for Alzheimer's Research, Washington Institute of Clinical Research, Vienna, VA, USA.
J Alzheimers Dis ; 87(1): 305-315, 2022.
Article in English | MEDLINE | ID: covidwho-1793085
ABSTRACT
Wang et al. analyze Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment accuracy as screening tests for detecting dementia associated with Alzheimer's disease (AD). Such tests are at the center of controversy regarding recognition and treatment of AD. The continued widespread use of tools such as MMSE (1975) underscores the failure of advancing cognitive screening and assessment, which has hampered the development and evaluation of AD treatments. It is time to employ readily available, efficient computerized measures for population/mass screening, clinical assessment of dementia progression, and accurate determination of approaches for prevention and treatment of AD and related conditions.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Alzheimer Disease / Cognitive Dysfunction Type of study: Experimental Studies / Prognostic study / Qualitative research Limits: Humans Language: English Journal: J Alzheimers Dis Journal subject: Geriatrics / Neurology Year: 2022 Document Type: Article Affiliation country: Jad-220211

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Alzheimer Disease / Cognitive Dysfunction Type of study: Experimental Studies / Prognostic study / Qualitative research Limits: Humans Language: English Journal: J Alzheimers Dis Journal subject: Geriatrics / Neurology Year: 2022 Document Type: Article Affiliation country: Jad-220211